HOUSE RX, INC.

Lobbying client · California · filed 2025 to 2026

Establishes on-site specialty pharmacies within physician group offices.

$110,000 Reported spend

12 Filings counted

3 Outside firms hired

4 Bills named

Spend is reported income plus in-house expenses across 12 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 3 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as HOUSE RX.

Who filed for this client 3

AVENUE SOLUTIONS $80,000 Outside firm · 4 filings
MARSHALL & POPP, LLC $30,000 Outside firm · 7 filings
FORBES-TATE $0 Outside firm · 1 filing

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings 4

H.R. 2484
Seniors’ Access to Critical Medications Act of 2025

5 filings
H.R. 5526
Seniors’ Access to Critical Medications Act of 2024

1 filing
S. 3458
Seniors’ Access to Critical Medications Act of 2023

1 filing
S. 3428
SAFE Crypto Act

1 filing

Reported by year 2 years

2026 $20,000 4 filings
2025 $90,000 8 filings

Issues lobbied 2

Medicare/Medicaid 6
Health Issues 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

SENATE 5
HOUSE OF REPRESENTATIVES 4

Recent filings 12 total

Q3 reportNo activity

MARSHALL & POPP, LLC

3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 20, 2026

View → Q2 reportNo activity

MARSHALL & POPP, LLC

2nd Quarter 2026 (Apr 1 - June 30) · posted Jul 9, 2026

View → Q1 terminationNo activity

AVENUE SOLUTIONS

1st Quarter 2026 (Jan 1 - Mar 31) · $20,000 income · posted Apr 20, 2026

View → Q1 reportNo activity

MARSHALL & POPP, LLC

1st Quarter 2026 (Jan 1 - Mar 31) · posted Apr 17, 2026

View → Q4 report

AVENUE SOLUTIONS

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 20, 2026

View → Q4 report

MARSHALL & POPP, LLC

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $30,000 income · posted Jan 16, 2026

View → Q3 report

AVENUE SOLUTIONS

3rd Quarter 2025 (July 1 - Sep 30) · Senate · $10,000 income · posted Oct 20, 2025

View → Q3 report

MARSHALL & POPP, LLC

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · posted Oct 20, 2025

View → Registration

AVENUE SOLUTIONS

3rd Quarter 2025 (July 1 - Sep 30) · posted Oct 17, 2025

View → Q2 reportNo activity

MARSHALL & POPP, LLC

2nd Quarter 2025 (Apr 1 - June 30) · posted Jul 21, 2025

View → Q1 reportNo activity

MARSHALL & POPP, LLC

1st Quarter 2025 (Jan 1 - Mar 31) · posted Apr 21, 2025

View → Q1 termination

FORBES-TATE

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · posted Apr 4, 2025

View →

Keep going

Filings through October 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.